Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of sequestering of triglyceride (GO:0010889) | 9.66146167 |
2 | triglyceride catabolic process (GO:0019433) | 9.15482232 |
3 | white fat cell differentiation (GO:0050872) | 8.85647508 |
4 | acylglycerol catabolic process (GO:0046464) | 8.22352453 |
5 | neutral lipid catabolic process (GO:0046461) | 8.22352453 |
6 | valine metabolic process (GO:0006573) | 8.05342201 |
7 | * brown fat cell differentiation (GO:0050873) | 7.41499330 |
8 | * low-density lipoprotein particle clearance (GO:0034383) | 7.18080586 |
9 | biotin metabolic process (GO:0006768) | 7.06534731 |
10 | lipid particle organization (GO:0034389) | 6.62751341 |
11 | regulation of cholesterol storage (GO:0010885) | 6.59254680 |
12 | triglyceride biosynthetic process (GO:0019432) | 6.38845360 |
13 | positive regulation of fatty acid oxidation (GO:0046321) | 6.19131540 |
14 | glycerolipid catabolic process (GO:0046503) | 6.15929312 |
15 | neutral lipid biosynthetic process (GO:0046460) | 6.09881475 |
16 | acylglycerol biosynthetic process (GO:0046463) | 6.09881475 |
17 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 6.02752443 |
18 | fatty acid transmembrane transport (GO:1902001) | 5.98566996 |
19 | lipid storage (GO:0019915) | 5.41746982 |
20 | branched-chain amino acid metabolic process (GO:0009081) | 5.36211175 |
21 | carnitine shuttle (GO:0006853) | 5.30883068 |
22 | branched-chain amino acid catabolic process (GO:0009083) | 5.24701271 |
23 | response to dietary excess (GO:0002021) | 5.17092203 |
24 | ethanol oxidation (GO:0006069) | 5.09422041 |
25 | triglyceride metabolic process (GO:0006641) | 4.98760253 |
26 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 4.96303268 |
27 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 4.94455745 |
28 | polyol transport (GO:0015791) | 4.90260882 |
29 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.86297040 |
30 | thioester biosynthetic process (GO:0035384) | 4.85302769 |
31 | acyl-CoA biosynthetic process (GO:0071616) | 4.85302769 |
32 | fatty-acyl-CoA metabolic process (GO:0035337) | 4.84526873 |
33 | regulation of fatty acid oxidation (GO:0046320) | 4.74648354 |
34 | acylglycerol metabolic process (GO:0006639) | 4.70673649 |
35 | * fatty acid beta-oxidation (GO:0006635) | 4.69346726 |
36 | coenzyme A biosynthetic process (GO:0015937) | 4.69344927 |
37 | neutral lipid metabolic process (GO:0006638) | 4.64303105 |
38 | regulation of fatty acid beta-oxidation (GO:0031998) | 4.61820522 |
39 | cellular response to lithium ion (GO:0071285) | 4.54391989 |
40 | fatty acid homeostasis (GO:0055089) | 4.53141678 |
41 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 4.49698941 |
42 | response to phenylpropanoid (GO:0080184) | 4.49539478 |
43 | alpha-linolenic acid metabolic process (GO:0036109) | 4.49301384 |
44 | negative regulation of lipid storage (GO:0010888) | 4.41795383 |
45 | positive regulation of lipid catabolic process (GO:0050996) | 4.33324308 |
46 | carnitine transmembrane transport (GO:1902603) | 4.31378284 |
47 | pentose-phosphate shunt (GO:0006098) | 4.29414690 |
48 | * fatty acid oxidation (GO:0019395) | 4.28776171 |
49 | positive regulation of glycolytic process (GO:0045821) | 4.27749629 |
50 | ovulation from ovarian follicle (GO:0001542) | 4.25782644 |
51 | positive regulation of lipid storage (GO:0010884) | 4.24488015 |
52 | NADPH regeneration (GO:0006740) | 4.23395079 |
53 | * lipid oxidation (GO:0034440) | 4.20390272 |
54 | tricarboxylic acid metabolic process (GO:0072350) | 4.16333237 |
55 | primary alcohol metabolic process (GO:0034308) | 4.15074954 |
56 | complement activation, alternative pathway (GO:0006957) | 4.11592970 |
57 | acetyl-CoA metabolic process (GO:0006084) | 4.07886587 |
58 | NADH metabolic process (GO:0006734) | 4.06568743 |
59 | * fatty acid catabolic process (GO:0009062) | 4.03737391 |
60 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 4.02234852 |
61 | negative regulation of amino acid transport (GO:0051956) | 3.99143922 |
62 | cGMP-mediated signaling (GO:0019934) | 3.98605190 |
63 | retinol metabolic process (GO:0042572) | 3.97614707 |
64 | amino-acid betaine transport (GO:0015838) | 3.96215142 |
65 | carnitine transport (GO:0015879) | 3.96215142 |
66 | ethanol metabolic process (GO:0006067) | 3.94170368 |
67 | regulation of gonadotropin secretion (GO:0032276) | 3.91333339 |
68 | oxaloacetate metabolic process (GO:0006107) | 3.88629846 |
69 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 3.86321874 |
70 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 3.85807977 |
71 | growth hormone receptor signaling pathway (GO:0060396) | 3.84314733 |
72 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 3.82851333 |
73 | diacylglycerol metabolic process (GO:0046339) | 3.80046560 |
74 | regulation of lipid storage (GO:0010883) | 3.78124536 |
75 | glycerol metabolic process (GO:0006071) | 3.77393243 |
76 | regulation of triglyceride catabolic process (GO:0010896) | 3.77054889 |
77 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.76772704 |
78 | protein localization to cell surface (GO:0034394) | 3.71681524 |
79 | L-serine transport (GO:0015825) | 3.62725788 |
80 | regulation of triglyceride biosynthetic process (GO:0010866) | 3.60643160 |
81 | regulation of triglyceride metabolic process (GO:0090207) | 3.59855002 |
82 | negative regulation of lipid catabolic process (GO:0050995) | 3.59009951 |
83 | coenzyme A metabolic process (GO:0015936) | 3.58386360 |
84 | response to hydroperoxide (GO:0033194) | 3.57993594 |
85 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.57795701 |
86 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.57795701 |
87 | thioester metabolic process (GO:0035383) | 3.57728067 |
88 | acyl-CoA metabolic process (GO:0006637) | 3.57728067 |
89 | * plasma lipoprotein particle clearance (GO:0034381) | 3.57193737 |
90 | phospholipid homeostasis (GO:0055091) | 3.56588702 |
91 | intracellular lipid transport (GO:0032365) | 3.54631254 |
92 | CDP-diacylglycerol metabolic process (GO:0046341) | 3.46625844 |
93 | cellular response to growth hormone stimulus (GO:0071378) | 3.43485996 |
94 | long-chain fatty acid transport (GO:0015909) | 3.43371663 |
95 | glomerular filtration (GO:0003094) | 3.43082312 |
96 | tricarboxylic acid cycle (GO:0006099) | 3.42933375 |
97 | regulation of lipoprotein metabolic process (GO:0050746) | 3.41844032 |
98 | succinate metabolic process (GO:0006105) | 3.40675639 |
99 | * negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.39762906 |
100 | endocrine hormone secretion (GO:0060986) | 3.37909489 |
101 | acylglycerol homeostasis (GO:0055090) | 3.37777936 |
102 | triglyceride homeostasis (GO:0070328) | 3.37777936 |
103 | phosphatidic acid metabolic process (GO:0046473) | 3.37660036 |
104 | phosphatidic acid biosynthetic process (GO:0006654) | 3.37660036 |
105 | 2-oxoglutarate metabolic process (GO:0006103) | 3.36029527 |
106 | * positive regulation of fatty acid metabolic process (GO:0045923) | 3.34043154 |
107 | barbed-end actin filament capping (GO:0051016) | 3.33201781 |
108 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.33038728 |
109 | alditol metabolic process (GO:0019400) | 3.32520593 |
110 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.26859346 |
111 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.26187916 |
112 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.26097165 |
113 | cellular response to vitamin (GO:0071295) | 3.25806175 |
114 | * regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.23530379 |
115 | * fat cell differentiation (GO:0045444) | 3.20554329 |
116 | transcytosis (GO:0045056) | 3.19310348 |
117 | regulation of lipid catabolic process (GO:0050994) | 3.18057032 |
118 | glucose catabolic process (GO:0006007) | 3.17774037 |
119 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.16793187 |
120 | positive regulation of histone deacetylation (GO:0031065) | 3.15058496 |
121 | lipoprotein transport (GO:0042953) | 3.14801124 |
122 | * cellular lipid catabolic process (GO:0044242) | 3.14214286 |
123 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.13879641 |
124 | cellular response to leptin stimulus (GO:0044320) | 3.13046844 |
125 | serine transport (GO:0032329) | 3.12078529 |
126 | positive regulation of macrophage cytokine production (GO:0060907) | 3.11694368 |
127 | negative regulation of organic acid transport (GO:0032891) | 3.10938265 |
128 | adaptation of signaling pathway (GO:0023058) | 3.10464998 |
129 | response to lipoprotein particle (GO:0055094) | 3.10407988 |
130 | negative regulation of appetite (GO:0032099) | 3.09455859 |
131 | negative regulation of response to food (GO:0032096) | 3.09455859 |
132 | phagocytosis, recognition (GO:0006910) | 3.06437717 |
133 | response to vitamin E (GO:0033197) | 3.05319476 |
134 | apoptotic cell clearance (GO:0043277) | 3.02045475 |
135 | renal filtration (GO:0097205) | 3.00257573 |
136 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.95961573 |
137 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.93965061 |
138 | response to nitrosative stress (GO:0051409) | 2.91922785 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 6.75990397 |
2 | CLOCK_20551151_ChIP-Seq_293T_Human | 4.77289023 |
3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.90471367 |
4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.73648466 |
5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.69731616 |
6 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 2.63165549 |
7 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.56741897 |
8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.56545582 |
9 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.54774746 |
10 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.19294840 |
11 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 2.15051218 |
12 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 15.8577760 |
13 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.95677238 |
14 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.88860362 |
15 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.84375372 |
16 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.82594058 |
17 | GATA1_22025678_ChIP-Seq_K562_Human | 1.79690844 |
18 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.71894967 |
19 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.71612506 |
20 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.64219962 |
21 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.61987953 |
22 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.60697824 |
23 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.52053426 |
24 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.50196878 |
25 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.48697127 |
26 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.47936360 |
27 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.45018668 |
28 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.41928351 |
29 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.33336356 |
30 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.32718047 |
31 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.31121833 |
32 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.30456248 |
33 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.29227259 |
34 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.27342657 |
35 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.25154472 |
36 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.25154472 |
37 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.24049662 |
38 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.23790773 |
39 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.23401847 |
40 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.23030613 |
41 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.09606169 |
42 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.08677272 |
43 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.08674921 |
44 | CJUN_26792858_Chip-Seq_BT549_Human | 1.05732420 |
45 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.05382050 |
46 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.04445915 |
47 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.04353691 |
48 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.02376796 |
49 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01142665 |
50 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.99921710 |
51 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.98807087 |
52 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.98751386 |
53 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.98705930 |
54 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.97946681 |
55 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.97326889 |
56 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.97300079 |
57 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.96654164 |
58 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.96476519 |
59 | CBP_21632823_ChIP-Seq_H3396_Human | 0.96087312 |
60 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.95269115 |
61 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.95043492 |
62 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.93630792 |
63 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.93344581 |
64 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.90389937 |
65 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.88620586 |
66 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.88500219 |
67 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.88178601 |
68 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.88016401 |
69 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.87944840 |
70 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.86006768 |
71 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.85988614 |
72 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.85468292 |
73 | RXR_22108803_ChIP-Seq_LS180_Human | 0.85256162 |
74 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.83943271 |
75 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.83390539 |
76 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.83390539 |
77 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.83197835 |
78 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.82908066 |
79 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.82508121 |
80 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.82392262 |
81 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.81256443 |
82 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.81175499 |
83 | GATA1_19941826_ChIP-Seq_K562_Human | 0.79789616 |
84 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.78588191 |
85 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.77647832 |
86 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.77190176 |
87 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.75179426 |
88 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.74900148 |
89 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.74743725 |
90 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.73618608 |
91 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.73099012 |
92 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.71982609 |
93 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.71762141 |
94 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.71451497 |
95 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.69169496 |
96 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.69046746 |
97 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.69039468 |
98 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.68921615 |
99 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.68476693 |
100 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.68149568 |
101 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.67876114 |
102 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.67876114 |
103 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.67598554 |
104 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.67089852 |
105 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.66131279 |
106 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.65342699 |
107 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.64845316 |
108 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.64437710 |
109 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.64345111 |
110 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.63509542 |
111 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.63385890 |
112 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.63074950 |
113 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.62896619 |
114 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.62700851 |
115 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.62089689 |
116 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.62029040 |
117 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.61875145 |
118 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.61683931 |
119 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.61560067 |
120 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.61309151 |
121 | GATA2_19941826_ChIP-Seq_K562_Human | 0.61200762 |
122 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.61072528 |
123 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.60741118 |
124 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.60275353 |
125 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.60092297 |
126 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.59497674 |
127 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.58729911 |
128 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.57887248 |
129 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.57620721 |
130 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.56975187 |
131 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.56824663 |
132 | ATF3_27146783_Chip-Seq_COLON_Human | 0.56298722 |
133 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.56074810 |
134 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.55837378 |
135 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.55689136 |
136 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.54155569 |
137 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.53539842 |
138 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.53021246 |
139 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.52620406 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005670_abnormal_white_adipose | 8.40929985 |
2 | MP0005666_abnormal_adipose_tissue | 5.78179322 |
3 | MP0004185_abnormal_adipocyte_glucose | 5.31391950 |
4 | MP0004130_abnormal_muscle_cell | 5.29734798 |
5 | MP0008438_abnormal_cutaneous_collagen | 4.57892380 |
6 | MP0005375_adipose_tissue_phenotype | 4.31429887 |
7 | MP0000013_abnormal_adipose_tissue | 3.52114610 |
8 | MP0002971_abnormal_brown_adipose | 3.24580487 |
9 | MP0002837_dystrophic_cardiac_calcinosis | 3.18418979 |
10 | MP0000003_abnormal_adipose_tissue | 3.10537354 |
11 | MP0005275_abnormal_skin_tensile | 2.93756215 |
12 | MP0002876_abnormal_thyroid_physiology | 2.91913243 |
13 | MP0010329_abnormal_lipoprotein_level | 2.86424784 |
14 | MP0009115_abnormal_fat_cell | 2.83907045 |
15 | MP0005334_abnormal_fat_pad | 2.61239560 |
16 | MP0003191_abnormal_cellular_cholesterol | 2.38264620 |
17 | MP0001661_extended_life_span | 2.32071825 |
18 | MP0002970_abnormal_white_adipose | 2.25869548 |
19 | MP0003011_delayed_dark_adaptation | 2.18441557 |
20 | MP0005503_abnormal_tendon_morphology | 2.16807872 |
21 | MP0003705_abnormal_hypodermis_morpholog | 2.04627446 |
22 | MP0003959_abnormal_lean_body | 1.92197193 |
23 | * MP0002118_abnormal_lipid_homeostasis | 1.91146525 |
24 | MP0005535_abnormal_body_temperature | 1.90264342 |
25 | MP0004272_abnormal_basement_membrane | 1.89210583 |
26 | MP0003868_abnormal_feces_composition | 1.87725065 |
27 | MP0003724_increased_susceptibility_to | 1.70544836 |
28 | MP0003690_abnormal_glial_cell | 1.49022530 |
29 | * MP0005452_abnormal_adipose_tissue | 1.32514307 |
30 | * MP0005448_abnormal_energy_balance | 1.31225055 |
31 | MP0005365_abnormal_bile_salt | 1.26299027 |
32 | * MP0000609_abnormal_liver_physiology | 1.22228182 |
33 | * MP0002078_abnormal_glucose_homeostasis | 1.20927711 |
34 | MP0002060_abnormal_skin_morphology | 1.20645764 |
35 | MP0009780_abnormal_chondrocyte_physiolo | 1.17091349 |
36 | MP0002909_abnormal_adrenal_gland | 1.15324173 |
37 | MP0008775_abnormal_heart_ventricle | 1.14580634 |
38 | MP0001501_abnormal_sleep_pattern | 1.11467511 |
39 | MP0002166_altered_tumor_susceptibility | 1.10696290 |
40 | MP0002796_impaired_skin_barrier | 1.09848695 |
41 | MP0002254_reproductive_system_inflammat | 1.06600511 |
42 | MP0003045_fibrosis | 1.06469926 |
43 | MP0000343_altered_response_to | 1.00177833 |
44 | MP0001727_abnormal_embryo_implantation | 0.97771453 |
45 | MP0000750_abnormal_muscle_regeneration | 0.97642996 |
46 | MP0000751_myopathy | 0.95730500 |
47 | MP0010368_abnormal_lymphatic_system | 0.95556912 |
48 | MP0002933_joint_inflammation | 0.94552017 |
49 | MP0003221_abnormal_cardiomyocyte_apopto | 0.94236663 |
50 | MP0003566_abnormal_cell_adhesion | 0.90984544 |
51 | MP0002006_tumorigenesis | 0.88247027 |
52 | MP0003646_muscle_fatigue | 0.86647713 |
53 | MP0002139_abnormal_hepatobiliary_system | 0.85870190 |
54 | MP0006276_abnormal_autonomic_nervous | 0.85086624 |
55 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.84746401 |
56 | MP0004084_abnormal_cardiac_muscle | 0.84139950 |
57 | MP0001764_abnormal_homeostasis | 0.83836811 |
58 | MP0004147_increased_porphyrin_level | 0.83060730 |
59 | MP0008961_abnormal_basal_metabolism | 0.82545814 |
60 | MP0003950_abnormal_plasma_membrane | 0.82396431 |
61 | MP0001756_abnormal_urination | 0.82036744 |
62 | MP0000767_abnormal_smooth_muscle | 0.81614385 |
63 | * MP0003186_abnormal_redox_activity | 0.78534367 |
64 | MP0006036_abnormal_mitochondrial_physio | 0.78389936 |
65 | MP0002638_abnormal_pupillary_reflex | 0.75932400 |
66 | * MP0001881_abnormal_mammary_gland | 0.74531481 |
67 | MP0002168_other_aberrant_phenotype | 0.74279249 |
68 | * MP0005385_cardiovascular_system_phenoty | 0.73513899 |
69 | * MP0001544_abnormal_cardiovascular_syste | 0.73513899 |
70 | MP0002332_abnormal_exercise_endurance | 0.73082540 |
71 | MP0005319_abnormal_enzyme/_coenzyme | 0.72280947 |
72 | * MP0005595_abnormal_vascular_smooth | 0.71861625 |
73 | * MP0005620_abnormal_muscle_contractility | 0.71487058 |
74 | MP0005379_endocrine/exocrine_gland_phen | 0.68924617 |
75 | * MP0003953_abnormal_hormone_level | 0.68664051 |
76 | MP0001177_atelectasis | 0.67800401 |
77 | * MP0004087_abnormal_muscle_fiber | 0.67191583 |
78 | * MP0003948_abnormal_gas_homeostasis | 0.66847187 |
79 | * MP0000759_abnormal_skeletal_muscle | 0.66260243 |
80 | MP0004782_abnormal_surfactant_physiolog | 0.66015923 |
81 | MP0000749_muscle_degeneration | 0.64821634 |
82 | MP0001944_abnormal_pancreas_morphology | 0.63989691 |
83 | MP0009672_abnormal_birth_weight | 0.61460393 |
84 | MP0005645_abnormal_hypothalamus_physiol | 0.60026004 |
85 | MP0001879_abnormal_lymphatic_vessel | 0.59926178 |
86 | MP0005332_abnormal_amino_acid | 0.59768236 |
87 | MP0000427_abnormal_hair_cycle | 0.58524141 |
88 | MP0004036_abnormal_muscle_relaxation | 0.58448489 |
89 | MP0005076_abnormal_cell_differentiation | 0.58362975 |
90 | MP0002295_abnormal_pulmonary_circulatio | 0.58113523 |
91 | MP0005508_abnormal_skeleton_morphology | 0.56448281 |
92 | MP0002108_abnormal_muscle_morphology | 0.56306266 |
93 | MP0005330_cardiomyopathy | 0.55992106 |
94 | MP0001533_abnormal_skeleton_physiology | 0.54844365 |
95 | MP0005266_abnormal_metabolism | 0.54712969 |
96 | MP0005360_urolithiasis | 0.54586406 |
97 | MP0005058_abnormal_lysosome_morphology | 0.53864585 |
98 | MP0004215_abnormal_myocardial_fiber | 0.52617842 |
99 | * MP0006138_congestive_heart_failure | 0.51491706 |
100 | MP0003075_altered_response_to | 0.50753063 |
101 | MP0001958_emphysema | 0.49324223 |
102 | * MP0003828_pulmonary_edema | 0.48648195 |
103 | * MP0009643_abnormal_urine_homeostasis | 0.48372622 |
104 | MP0005369_muscle_phenotype | 0.47207931 |
105 | MP0003879_abnormal_hair_cell | 0.47042321 |
106 | MP0004484_altered_response_of | 0.46344456 |
107 | MP0002998_abnormal_bone_remodeling | 0.46324359 |
108 | MP0003137_abnormal_impulse_conducting | 0.46239844 |
109 | * MP0005164_abnormal_response_to | 0.45973228 |
110 | MP0005165_increased_susceptibility_to | 0.45899178 |
111 | MP0005647_abnormal_sex_gland | 0.45767164 |
112 | MP0010630_abnormal_cardiac_muscle | 0.43273431 |
113 | MP0005167_abnormal_blood-brain_barrier | 0.42175798 |
114 | * MP0002972_abnormal_cardiac_muscle | 0.40715170 |
115 | MP0000598_abnormal_liver_morphology | 0.40604883 |
116 | MP0010234_abnormal_vibrissa_follicle | 0.40072531 |
117 | MP0000163_abnormal_cartilage_morphology | 0.39817864 |
118 | MP0005397_hematopoietic_system_phenotyp | 0.39475439 |
119 | MP0001545_abnormal_hematopoietic_system | 0.39475439 |
120 | * MP0009763_increased_sensitivity_to | 0.39450832 |
121 | MP0003279_aneurysm | 0.39096997 |
122 | * MP0000249_abnormal_blood_vessel | 0.38974283 |
123 | MP0002009_preneoplasia | 0.38365249 |
124 | MP0004858_abnormal_nervous_system | 0.38098291 |
125 | MP0004883_abnormal_blood_vessel | 0.37410696 |
126 | * MP0000230_abnormal_systemic_arterial | 0.36505477 |
127 | MP0005390_skeleton_phenotype | 0.36201675 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Oligomenorrhea (HP:0000876) | 8.95178411 |
2 | Acanthosis nigricans (HP:0000956) | 7.51867006 |
3 | Hypertriglyceridemia (HP:0002155) | 6.53191248 |
4 | Hyperglycinuria (HP:0003108) | 5.53616686 |
5 | Insulin-resistant diabetes mellitus (HP:0000831) | 4.84290269 |
6 | Complement deficiency (HP:0004431) | 4.70563773 |
7 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.60366767 |
8 | Abnormality of glycine metabolism (HP:0010895) | 4.60366767 |
9 | Difficulty running (HP:0009046) | 4.27715245 |
10 | Myoglobinuria (HP:0002913) | 3.96032478 |
11 | Long foot (HP:0001833) | 3.88519557 |
12 | Reduced subcutaneous adipose tissue (HP:0003758) | 3.76096570 |
13 | Insulin resistance (HP:0000855) | 3.68191269 |
14 | Growth hormone excess (HP:0000845) | 3.52864209 |
15 | Ankle contracture (HP:0006466) | 3.50114392 |
16 | Increased connective tissue (HP:0009025) | 3.49586852 |
17 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.48972430 |
18 | Pigmentary retinal degeneration (HP:0001146) | 3.47565092 |
19 | Hypoalphalipoproteinemia (HP:0003233) | 3.43555829 |
20 | Increased muscle lipid content (HP:0009058) | 3.41975243 |
21 | Epidermoid cyst (HP:0200040) | 3.41460052 |
22 | Hypoglycemic coma (HP:0001325) | 3.37997300 |
23 | Bone cyst (HP:0012062) | 3.36531965 |
24 | Abnormality of complement system (HP:0005339) | 3.33741189 |
25 | Subcapsular cataract (HP:0000523) | 3.24094725 |
26 | Ketoacidosis (HP:0001993) | 3.22459471 |
27 | Back pain (HP:0003418) | 3.22020962 |
28 | Hydroxyprolinuria (HP:0003080) | 3.17627420 |
29 | Abnormality of proline metabolism (HP:0010907) | 3.17627420 |
30 | Nausea (HP:0002018) | 3.16672663 |
31 | Myocardial infarction (HP:0001658) | 3.14761055 |
32 | Hemorrhage of the eye (HP:0011885) | 3.13819313 |
33 | Type 1 muscle fiber predominance (HP:0003803) | 3.10952241 |
34 | Rhabdomyolysis (HP:0003201) | 3.09787967 |
35 | Vertebral compression fractures (HP:0002953) | 3.09251518 |
36 | Ketosis (HP:0001946) | 3.07973869 |
37 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.06283925 |
38 | Ectopia lentis (HP:0001083) | 3.05652501 |
39 | Multiple enchondromatosis (HP:0005701) | 3.05368080 |
40 | Hyperthyroidism (HP:0000836) | 3.01118197 |
41 | Hyperlipoproteinemia (HP:0010980) | 3.00958346 |
42 | Increased variability in muscle fiber diameter (HP:0003557) | 3.00411021 |
43 | Axonal loss (HP:0003447) | 2.97683116 |
44 | Broad metatarsal (HP:0001783) | 2.95141978 |
45 | Follicular hyperkeratosis (HP:0007502) | 2.93990107 |
46 | Cerebral aneurysm (HP:0004944) | 2.91432368 |
47 | Large hands (HP:0001176) | 2.91211783 |
48 | Polycythemia (HP:0001901) | 2.80251475 |
49 | Hyperglycinemia (HP:0002154) | 2.77865347 |
50 | Frequent falls (HP:0002359) | 2.70329210 |
51 | Spinal rigidity (HP:0003306) | 2.69751119 |
52 | Dicarboxylic aciduria (HP:0003215) | 2.65600328 |
53 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.65600328 |
54 | Thyroid-stimulating hormone excess (HP:0002925) | 2.64660269 |
55 | Hyperpituitarism (HP:0010514) | 2.64055385 |
56 | Skin nodule (HP:0200036) | 2.63871493 |
57 | Ileus (HP:0002595) | 2.61420201 |
58 | Striae distensae (HP:0001065) | 2.59526888 |
59 | Increased serum pyruvate (HP:0003542) | 2.56318858 |
60 | Pancreatitis (HP:0001733) | 2.55342878 |
61 | Hyperammonemia (HP:0001987) | 2.54220172 |
62 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.51591155 |
63 | Xanthomatosis (HP:0000991) | 2.50943209 |
64 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.50768185 |
65 | Colitis (HP:0002583) | 2.48159269 |
66 | Slender build (HP:0001533) | 2.48115481 |
67 | Toxemia of pregnancy (HP:0100603) | 2.47359764 |
68 | Infantile muscular hypotonia (HP:0008947) | 2.44540470 |
69 | Neck muscle weakness (HP:0000467) | 2.39698481 |
70 | Prenatal maternal abnormality (HP:0002686) | 2.39602795 |
71 | Decreased subcutaneous fat (HP:0001002) | 2.38272936 |
72 | Abnormal cartilage morphology (HP:0002763) | 2.34516809 |
73 | Facial shape deformation (HP:0011334) | 2.33446673 |
74 | Potter facies (HP:0002009) | 2.33446673 |
75 | Accelerated skeletal maturation (HP:0005616) | 2.32808792 |
76 | Facial diplegia (HP:0001349) | 2.32694336 |
77 | Lipoatrophy (HP:0100578) | 2.30177446 |
78 | Premature rupture of membranes (HP:0001788) | 2.26586330 |
79 | Hyperglycemia (HP:0003074) | 2.24616608 |
80 | Hypercholesterolemia (HP:0003124) | 2.24091605 |
81 | Lymphangioma (HP:0100764) | 2.23717101 |
82 | Polygenic inheritance (HP:0010982) | 2.23710404 |
83 | Pulmonary artery stenosis (HP:0004415) | 2.23391997 |
84 | Prominent supraorbital ridges (HP:0000336) | 2.19830069 |
85 | Tetraparesis (HP:0002273) | 2.19726331 |
86 | Enlarged penis (HP:0000040) | 2.19292824 |
87 | Muscle fiber splitting (HP:0003555) | 2.18474663 |
88 | Abnormality of glycolysis (HP:0004366) | 2.17076015 |
89 | Abnormality of subcutaneous fat tissue (HP:0001001) | 2.15786504 |
90 | Cervical subluxation (HP:0003308) | 2.11738911 |
91 | Aortic dissection (HP:0002647) | 2.09526204 |
92 | Abnormality of the periventricular white matter (HP:0002518) | 2.08676486 |
93 | Gowers sign (HP:0003391) | 2.07027309 |
94 | Hyporeflexia of lower limbs (HP:0002600) | 2.06383149 |
95 | Venous abnormality (HP:0002624) | 2.04772970 |
96 | Abnormal hemoglobin (HP:0011902) | 2.04343203 |
97 | Abnormal eating behavior (HP:0100738) | 2.04160589 |
98 | Polar cataract (HP:0010696) | 2.04073691 |
99 | Turricephaly (HP:0000262) | 2.00008457 |
100 | Easy fatigability (HP:0003388) | 1.99198663 |
101 | Hypercortisolism (HP:0001578) | 1.98433554 |
102 | Megalocornea (HP:0000485) | 1.98220232 |
103 | Wormian bones (HP:0002645) | 1.98206971 |
104 | Muscle stiffness (HP:0003552) | 1.97268952 |
105 | Aortic aneurysm (HP:0004942) | 1.94697340 |
106 | Vascular tortuosity (HP:0004948) | 1.93869928 |
107 | Systemic lupus erythematosus (HP:0002725) | 1.91581400 |
108 | Esophageal varix (HP:0002040) | 1.90911557 |
109 | Scapular winging (HP:0003691) | 1.88442731 |
110 | Shallow orbits (HP:0000586) | 1.87966369 |
111 | Protrusio acetabuli (HP:0003179) | 1.86143148 |
112 | Autoimmune thrombocytopenia (HP:0001973) | 1.84749906 |
113 | Glucose intolerance (HP:0000833) | 1.83859841 |
114 | Amyloidosis (HP:0011034) | 1.81181257 |
115 | Limb hypertonia (HP:0002509) | 1.80981478 |
116 | Generalized aminoaciduria (HP:0002909) | 1.80124945 |
117 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.79892840 |
118 | Abnormality of alanine metabolism (HP:0010916) | 1.79892840 |
119 | Hyperalaninemia (HP:0003348) | 1.79892840 |
120 | Dilatation of the ascending aorta (HP:0005111) | 1.79546278 |
121 | Increased mean platelet volume (HP:0011877) | 1.78746060 |
122 | Proximal amyotrophy (HP:0007126) | 1.78518159 |
123 | Polyphagia (HP:0002591) | 1.78093465 |
124 | Conjunctival hamartoma (HP:0100780) | 1.77552874 |
125 | Atrioventricular block (HP:0001678) | 1.77396270 |
126 | Right ventricular cardiomyopathy (HP:0011663) | 1.76655230 |
127 | Mitral valve prolapse (HP:0001634) | 1.76106560 |
128 | Clitoromegaly (HP:0000057) | 1.75821539 |
129 | Mutism (HP:0002300) | 1.74933851 |
130 | Rectal prolapse (HP:0002035) | 1.73230784 |
131 | Myotonia (HP:0002486) | 1.72470072 |
132 | Hepatic necrosis (HP:0002605) | 1.72084282 |
133 | Asymmetric septal hypertrophy (HP:0001670) | 1.72024133 |
134 | Impulsivity (HP:0100710) | 1.71187640 |
135 | Prolonged bleeding time (HP:0003010) | 1.69109532 |
136 | Adactyly (HP:0009776) | 1.68590794 |
137 | Mesangial abnormality (HP:0001966) | 1.67647542 |
138 | Buphthalmos (HP:0000557) | 1.67345241 |
Rank | Gene Set | Z-score |
---|---|---|
1 | CAMK1D | 6.51337072 |
2 | TRIB3 | 5.58375372 |
3 | CAMK1G | 4.73622967 |
4 | SIK1 | 4.51772950 |
5 | BCKDK | 4.36094134 |
6 | PDK3 | 3.04043442 |
7 | PDK4 | 3.04043442 |
8 | LMTK2 | 2.63006364 |
9 | RIPK1 | 2.55367414 |
10 | ERN1 | 2.37609074 |
11 | MST1R | 2.23473469 |
12 | TESK1 | 1.99411482 |
13 | CDK9 | 1.81222131 |
14 | PRKAA2 | 1.80381020 |
15 | FGFR2 | 1.78949472 |
16 | PDK2 | 1.76211125 |
17 | MAPK4 | 1.75864102 |
18 | INSRR | 1.73806824 |
19 | NLK | 1.73092742 |
20 | FRK | 1.63076284 |
21 | FGFR3 | 1.62173987 |
22 | GRK5 | 1.55928672 |
23 | PDGFRA | 1.49463076 |
24 | PKN2 | 1.35874753 |
25 | EPHB2 | 1.33624790 |
26 | MAP2K1 | 1.23590544 |
27 | CDK6 | 1.23567699 |
28 | MOS | 1.20262385 |
29 | ARAF | 1.19954265 |
30 | PIK3CA | 1.17514649 |
31 | MAP3K13 | 1.16182929 |
32 | TRPM7 | 1.16146785 |
33 | STK38L | 1.09992200 |
34 | ADRBK1 | 1.05333680 |
35 | DDR2 | 1.03503481 |
36 | PRKD3 | 1.02826927 |
37 | JAK1 | 1.00762837 |
38 | RIPK4 | 1.00727256 |
39 | MET | 0.99309743 |
40 | TGFBR2 | 0.98996860 |
41 | LATS1 | 0.98703496 |
42 | PHKG2 | 0.93140202 |
43 | PHKG1 | 0.93140202 |
44 | PRKAA1 | 0.92543525 |
45 | KIT | 0.89464523 |
46 | MAP3K6 | 0.88627240 |
47 | FGFR4 | 0.87632478 |
48 | MYLK | 0.85630377 |
49 | FES | 0.83475350 |
50 | PDPK1 | 0.83419116 |
51 | TTN | 0.83328489 |
52 | TIE1 | 0.80520796 |
53 | JAK2 | 0.79051793 |
54 | PRKG1 | 0.78978849 |
55 | CAMKK2 | 0.76863686 |
56 | PRKCH | 0.73483719 |
57 | FER | 0.72326500 |
58 | RET | 0.72118456 |
59 | NEK9 | 0.71865573 |
60 | LATS2 | 0.71376222 |
61 | FLT3 | 0.69365482 |
62 | PDGFRB | 0.67154606 |
63 | PDK1 | 0.67077797 |
64 | GRK1 | 0.65603916 |
65 | MTOR | 0.65448442 |
66 | IGF1R | 0.64568807 |
67 | TYK2 | 0.64409446 |
68 | ILK | 0.64392150 |
69 | CDC42BPA | 0.64017848 |
70 | MAPK7 | 0.63439277 |
71 | FGFR1 | 0.62791135 |
72 | MAPK3 | 0.61346204 |
73 | MAPK11 | 0.61242118 |
74 | PKN1 | 0.60035296 |
75 | PRKACG | 0.58970391 |
76 | IRAK3 | 0.57877546 |
77 | PAK2 | 0.57859695 |
78 | KDR | 0.57212030 |
79 | GSK3A | 0.56708801 |
80 | STK38 | 0.55055912 |
81 | CAMK1 | 0.54684649 |
82 | PTK2B | 0.54546668 |
83 | BMX | 0.54157770 |
84 | PRKACB | 0.53303677 |
85 | PTK2 | 0.51481372 |
86 | JAK3 | 0.51073520 |
87 | CLK1 | 0.50412019 |
88 | INSR | 0.49311453 |
89 | CDK4 | 0.48734885 |
90 | PRKD1 | 0.48721408 |
91 | ZAP70 | 0.48058356 |
92 | SGK2 | 0.47794560 |
93 | RPS6KB1 | 0.47372530 |
94 | SGK494 | 0.46085365 |
95 | SGK223 | 0.46085365 |
96 | AKT2 | 0.41076672 |
97 | KSR2 | 0.41020433 |
98 | DAPK2 | 0.40985082 |
99 | EIF2AK2 | 0.37991975 |
100 | EEF2K | 0.37663366 |
101 | PINK1 | 0.37227279 |
102 | DAPK3 | 0.37023029 |
103 | PRKACA | 0.36404223 |
104 | CSF1R | 0.35796263 |
105 | SRC | 0.35071356 |
106 | PRKD2 | 0.33738310 |
107 | MAPK1 | 0.33425687 |
108 | TGFBR1 | 0.33174511 |
109 | ABL2 | 0.32994900 |
110 | MARK1 | 0.32882966 |
111 | MAP3K1 | 0.32614456 |
112 | MAPKAPK5 | 0.31891962 |
113 | SGK3 | 0.31604931 |
114 | YES1 | 0.31298619 |
115 | IRAK2 | 0.30938337 |
116 | CSK | 0.30720838 |
117 | IRAK1 | 0.30257730 |
118 | PRPF4B | 0.30248959 |
119 | PRKG2 | 0.30221728 |
120 | MAP2K4 | 0.30063574 |
121 | CAMKK1 | 0.29750067 |
122 | MARK2 | 0.29383625 |
123 | HIPK2 | 0.29297864 |
124 | MAP2K3 | 0.29096506 |
125 | LRRK2 | 0.28653036 |
126 | TBK1 | 0.28463147 |
127 | TNK2 | 0.27223216 |
128 | MAPK12 | 0.26502984 |
129 | EPHB1 | 0.26034819 |
130 | STK11 | 0.24781676 |
131 | STK3 | 0.23086026 |
132 | PAK6 | 0.22454324 |
133 | ABL1 | 0.22389494 |
134 | ICK | 0.21650967 |
135 | PTK6 | 0.19666017 |
136 | AKT1 | 0.19189096 |
137 | TYRO3 | 0.18897348 |
138 | MAPKAPK3 | 0.18312518 |
139 | PRKCZ | 0.16217880 |
140 | RPS6KA3 | 0.15261092 |
141 | CDK5 | 0.13336213 |
142 | EPHA3 | 0.11805518 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 4.88158965 |
2 | Propanoate metabolism_Homo sapiens_hsa00640 | 4.70423732 |
3 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 4.60523260 |
4 | * PPAR signaling pathway_Homo sapiens_hsa03320 | 4.16674749 |
5 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.80461667 |
6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.79134956 |
7 | Fatty acid metabolism_Homo sapiens_hsa01212 | 3.53293699 |
8 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 3.16757240 |
9 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.92268016 |
10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.91454686 |
11 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.32456428 |
12 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.07247764 |
13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.95482316 |
14 | Histidine metabolism_Homo sapiens_hsa00340 | 1.94388800 |
15 | Carbon metabolism_Homo sapiens_hsa01200 | 1.86705510 |
16 | * AMPK signaling pathway_Homo sapiens_hsa04152 | 1.84033833 |
17 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.81899657 |
18 | * Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.79078075 |
19 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.70976876 |
20 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.66531864 |
21 | Peroxisome_Homo sapiens_hsa04146 | 1.52413394 |
22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.36902654 |
23 | Insulin resistance_Homo sapiens_hsa04931 | 1.33230623 |
24 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.32510928 |
25 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.29582357 |
26 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.22920504 |
27 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.21050679 |
28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.19103872 |
29 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.14355379 |
30 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.14027652 |
31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.03694353 |
32 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.97434578 |
33 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.97219156 |
34 | Malaria_Homo sapiens_hsa05144 | 0.95131954 |
35 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.93430598 |
36 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.91972815 |
37 | Renin secretion_Homo sapiens_hsa04924 | 0.87774248 |
38 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.85779786 |
39 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.83344953 |
40 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.80800320 |
41 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.78229463 |
42 | Retinol metabolism_Homo sapiens_hsa00830 | 0.76703201 |
43 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.68420377 |
44 | * Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.67572889 |
45 | * Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.64895495 |
46 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.63782128 |
47 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.62976052 |
48 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.62599885 |
49 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.57583671 |
50 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.52681802 |
51 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.51857673 |
52 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.51392235 |
53 | ABC transporters_Homo sapiens_hsa02010 | 0.51163892 |
54 | Focal adhesion_Homo sapiens_hsa04510 | 0.51004770 |
55 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.50098943 |
56 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.48461038 |
57 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.47324008 |
58 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.46904793 |
59 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.44457145 |
60 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.43657276 |
61 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.42901508 |
62 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.41906651 |
63 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.41262019 |
64 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.40643639 |
65 | Lysine degradation_Homo sapiens_hsa00310 | 0.39548974 |
66 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.38528823 |
67 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.38254906 |
68 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.35881013 |
69 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.33858981 |
70 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.33597310 |
71 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.33577078 |
72 | Morphine addiction_Homo sapiens_hsa05032 | 0.32567632 |
73 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.31159574 |
74 | Thyroid cancer_Homo sapiens_hsa05216 | 0.30010866 |
75 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.28862024 |
76 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.28117225 |
77 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.27858279 |
78 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.26973997 |
79 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.26741867 |
80 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.26146432 |
81 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.26125198 |
82 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.24189690 |
83 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.23288650 |
84 | Amoebiasis_Homo sapiens_hsa05146 | 0.21672462 |
85 | Melanoma_Homo sapiens_hsa05218 | 0.21297024 |
86 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.20710862 |
87 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.20077176 |
88 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.19424453 |
89 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.19358924 |
90 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.19274816 |
91 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.19069684 |
92 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.17480976 |
93 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.16733423 |
94 | Sulfur relay system_Homo sapiens_hsa04122 | 0.15820105 |
95 | Lysosome_Homo sapiens_hsa04142 | 0.14766197 |
96 | Metabolic pathways_Homo sapiens_hsa01100 | 0.14589713 |
97 | Salivary secretion_Homo sapiens_hsa04970 | 0.14392972 |
98 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.13935393 |
99 | Circadian rhythm_Homo sapiens_hsa04710 | 0.12903897 |
100 | Melanogenesis_Homo sapiens_hsa04916 | 0.12621545 |
101 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.12607483 |
102 | Bile secretion_Homo sapiens_hsa04976 | 0.12343796 |
103 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.11581973 |
104 | Cocaine addiction_Homo sapiens_hsa05030 | 0.11285210 |
105 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.10816796 |
106 | Viral myocarditis_Homo sapiens_hsa05416 | 0.09990699 |
107 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.09868821 |
108 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.09643109 |
109 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.09533091 |
110 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.09203996 |
111 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.08047766 |
112 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.07877659 |
113 | * Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.07839036 |
114 | Glioma_Homo sapiens_hsa05214 | 0.07683044 |
115 | Gap junction_Homo sapiens_hsa04540 | 0.07460569 |
116 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.07331948 |
117 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.07249247 |
118 | Platelet activation_Homo sapiens_hsa04611 | 0.07048342 |
119 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.06939081 |
120 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.06367028 |
121 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.06102763 |
122 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.05268798 |
123 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.05047431 |
124 | Adherens junction_Homo sapiens_hsa04520 | 0.04784441 |
125 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.04022280 |
126 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.03796793 |
127 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.03676247 |
128 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.03007142 |
129 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.02441065 |
130 | Pathways in cancer_Homo sapiens_hsa05200 | 0.02415862 |
131 | Prion diseases_Homo sapiens_hsa05020 | 0.01169024 |
132 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.00448700 |